These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 12032324
1. UL40-mediated NK evasion during productive infection with human cytomegalovirus. Wang EC, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK, Braud VM, Wilkinson GW. Proc Natl Acad Sci U S A; 2002 May 28; 99(11):7570-5. PubMed ID: 12032324 [Abstract] [Full Text] [Related]
2. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A. Eur J Immunol; 2003 Jun 28; 33(6):1657-66. PubMed ID: 12778484 [Abstract] [Full Text] [Related]
3. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. López-Botet M, Angulo A, Gumá M. Tissue Antigens; 2004 Mar 28; 63(3):195-203. PubMed ID: 14989708 [Abstract] [Full Text] [Related]
4. Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity. Cerboni C, Mousavi-Jazi M, Wakiguchi H, Carbone E, Kärre K, Söderström K. Eur J Immunol; 2001 Oct 28; 31(10):2926-35. PubMed ID: 11592068 [Abstract] [Full Text] [Related]
5. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Monsiváis-Urenda A, Noyola-Cherpitel D, Hernández-Salinas A, García-Sepúlveda C, Romo N, Baranda L, López-Botet M, González-Amaro R. Eur J Immunol; 2010 May 28; 40(5):1418-27. PubMed ID: 20201038 [Abstract] [Full Text] [Related]
6. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity. Cederarv M, Söderberg-Nauclér C, Odeberg J. Immunobiology; 2009 May 28; 214(5):331-41. PubMed ID: 19152985 [Abstract] [Full Text] [Related]
7. Human leukocyte antigen E in human cytomegalovirus infection: friend or foe? Gong F, Song S, Lv G, Pan Y, Zhang D, Jiang H. Acta Biochim Biophys Sin (Shanghai); 2012 Jul 28; 44(7):551-4. PubMed ID: 22576308 [Abstract] [Full Text] [Related]
9. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. Fletcher JM, Prentice HG, Grundy JE. J Immunol; 1998 Sep 01; 161(5):2365-74. PubMed ID: 9725232 [Abstract] [Full Text] [Related]
10. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues. Wada H, Matsumoto N, Maenaka K, Suzuki K, Yamamoto K. Eur J Immunol; 2004 Jan 01; 34(1):81-90. PubMed ID: 14971033 [Abstract] [Full Text] [Related]
11. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ. Nature; 1997 Apr 03; 386(6624):510-4. PubMed ID: 9087412 [Abstract] [Full Text] [Related]
14. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells. Kusumi M, Yamashita T, Fujii T, Nagamatsu T, Kozuma S, Taketani Y. J Reprod Immunol; 2006 Jun 03; 70(1-2):33-42. PubMed ID: 16488482 [Abstract] [Full Text] [Related]
15. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Welte SA, Sinzger C, Lutz SZ, Singh-Jasuja H, Sampaio KL, Eknigk U, Rammensee HG, Steinle A. Eur J Immunol; 2003 Jan 03; 33(1):194-203. PubMed ID: 12594848 [Abstract] [Full Text] [Related]
16. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Reyburn HT, Mandelboim O, Valés-Gómez M, Davis DM, Pazmany L, Strominger JL. Nature; 1997 Apr 03; 386(6624):514-7. PubMed ID: 9087413 [Abstract] [Full Text] [Related]
17. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells. Heatley SL, Pietra G, Lin J, Widjaja JML, Harpur CM, Lester S, Rossjohn J, Szer J, Schwarer A, Bradstock K, Bardy PG, Mingari MC, Moretta L, Sullivan LC, Brooks AG. J Biol Chem; 2013 Mar 22; 288(12):8679-8690. PubMed ID: 23335510 [Abstract] [Full Text] [Related]
18. Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets. Llano M, Gumá M, Ortega M, Angulo A, López-Botet M. Eur J Immunol; 2003 Oct 22; 33(10):2744-54. PubMed ID: 14515258 [Abstract] [Full Text] [Related]
19. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Lilienfeld BG, Crew MD, Forte P, Baumann BC, Seebach JD. Xenotransplantation; 2007 Mar 22; 14(2):126-34. PubMed ID: 17381687 [Abstract] [Full Text] [Related]
20. Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors. Lang P, Griesinger A, Hamprecht K, Feuchtinger T, Schumm M, Neuhäuser F, Greil J, Martin D, Handgretinger R, Niethammer D. Hum Immunol; 2004 May 22; 65(5):423-31. PubMed ID: 15172441 [Abstract] [Full Text] [Related] Page: [Next] [New Search]